Metraipolis › archive › dc_ee53555c69fb

An Optimal Spray Device for the Nose-to-Brain Delivery of AmyP53, an Adaptive Therapeutic Peptide for Alzheimer's and Parkinson's Diseases — Europe PMC PMID:42654104

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654104
DOI
10.3390/pharmaceutics18080987
License (as archived)
solo-consultazione
Archived
2026-10-16T21:55:33.024Z
SHA-256 of the archived text
24fe12147efd861640c4189533c6ba9a1e9cb78efae7be10e2de860d5a7b8fb4
Stable URL of this page
https://metraipolis.com/documento/dc_ee53555c69fb

How to cite

An Optimal Spray Device for the Nose-to-Brain Delivery of AmyP53, an Adaptive Therapeutic Peptide for Alzheimer's and Parkinson's Diseases — Europe PMC PMID:42654104 — Europe PMC (en), https://europepmc.org/article/MED/42654104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee53555c69fb (Metraipolis archive dc_ee53555c69fb, sha256 24fe12147efd861640c4189533c6ba9a1e9cb78efae7be10e2de860d5a7b8fb4)
BibTeX
@misc{dcee53555c69fb,
  title = {An Optimal Spray Device for the Nose-to-Brain Delivery of AmyP53, an Adaptive Therapeutic Peptide for Alzheimer's and Parkinson's Diseases — Europe PMC PMID:42654104},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654104},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee53555c69fb; sha256 24fe12147efd861640c4189533c6ba9a1e9cb78efae7be10e2de860d5a7b8fb4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654104. Agents can read the archived copy with the MCP tool read_document.